搜索筛选:
搜索耗时1.2489秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
First-line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/beva
[会议论文] 作者：Qing Chang,Tianqing Chu,
来源：2019中国肿瘤学大会 年份：2019
Objective Background The study was conducted to compare the effectiveness and safety of pemetrexed/carboplatin or cisplatin/bevacizumab(PemPBev)and paclitaxel/carboplatin/bevacizumab(PacCBev)as first-...
[会议论文] 作者：Baohui Han,Tianqing Chu,Kai Li,
来源：2019中国肿瘤学大会 年份：2019
...
[期刊论文] 作者：Aiqin Gu,Chunlei Shi,Liwen Xiong,Tianqing Chu,Jun Pei,Baohui Han,,
来源：Chinese Journal of Cancer Research 年份：2013
Objective: To evaluate the efficacy and safety of icotinib hydrochloride in patients with advanced non-small cell lung cancer (NSCLC). Methods: A total of 89 pa...
[会议论文] 作者：Jun Pei,Baohui Han,Tianqing Chu,Minhua Shao,Jiajun Teng,Huifang Sha,Aiqing Gu,Rong Li,Jialin Qian,Weifeng,
来源：中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议 年份：2013
Background It has been found that HGF-dependent c-Met (HGFR) autocrine is activated in a wide variety of human primary and second malignancies.On the other hand, the metastatic growth potential of tum...
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer p
[期刊论文] 作者：Jun Lu,Tianqing Chu,Hongyu Liu,Minjuan Hu,Yuqing Lou,Yanwei Zhang,Zhiqiang Gao,Wei Zhang,Xueyan Zhang,
来源：中国癌症研究（英文版） 年份：2022
Objective:Anti-vascular endothelial growth factor(VEGF)monoclonal antibodies are an effective means of treating non-small cell lung cancer(NSCLC).Here,we aim to update the equivalent efficacy assessment between QL1101 and bevacizumab based ......
Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cel
[期刊论文] 作者：Tianqing Chu,Jun Lu,Minghong Bi,Helong Zhang,Wu Zhuang,Yan Yu,Jianhua Shi,Zhendong Chen,Xiaochun Zhang,
来源：癌症生物学与医学:英文版 年份：2021
Objective:This phase 3 study aimed to test equivalence in efficacy and safety for QL1101,a bevacizumab analogue in Chinese patients with untreated locally advanced non-squamous non-small cell lung cancer(NSCLC).Methods:Eligible patients wer......
相关搜索：
